Get a reply from this employer
Your resume and cover letter, tailored to exactly what they’re hiring for.
Moffitt Cancer Center is seeking a Postdoctoral Fellow in Bone Metastatic Cancer Biology to conduct innovative research in our lab. This fully funded position focuses on tumor progression and metastasis within the bone, particularly prostate cancer, multiple myeloma, and osteosarcoma. Join a team that integrates tumor biology, bone biology, and immunology to advance therapeutic strategies.
Candidates should have a Ph.D. in a relevant field and a strong background in cancer biology. This is an opportunity to be part of a mission-driven organization recognized for its workplace culture.
Working at Moffitt is both a career and a mission: to contribute to the prevention and cure of cancer. As the only National Cancer Institute-designated Comprehensive Cancer Center based in Florida, Moffitt employs some of the best and brightest minds from around the world. Join a dedicated team of nearly 11,000 who are shaping the future we envision. Moffitt has been recognized as a Best and Brightest Company to Work For in the Nation and is continually named one of the Tampa Bay Times’ Top Workplaces.
Summary
Postdoctoral Fellow – Bone Metastatic Cancer Biology. A fully funded postdoctoral position is available in the laboratory of Dr. Conor C. Lynch within the Department of Tumor Microenvironment & Metastasis at Moffitt Cancer Center. The Lynch laboratory studies the molecular and cellular mechanisms that drive tumor progression and metastasis within the bone microenvironment, with a particular focus on bone metastatic prostate cancer, multiple myeloma, and osteosarcoma. Research in the laboratory integrates tumor biology, bone biology, and immunology to understand how cancer cells interact with the bone niche and how these interactions promote tumor growth, therapy resistance, and disease progression. The laboratory has a strong translational focus, including the development and testing of novel small molecule inhibitors and therapeutic strategies targeting the tumor–bone microenvironment.